Gelsyn-3 (hyaluronate sodium)
Visco-Elastics, Intra-articular Intraarticular Syringe (Ml)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Generic name: hyaluronate sodium
Drug class: Visco-Elastics, Intra-articular
Therapeutic class: Locomotor System
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Gelsyn-3
Indications
The following indications are listed for Gelsyn-3:
- Osteoarthritis Of The Knee
Also known as: Degenerative Arthritis Of The Knee, Degenerative Joint Disease Of The Knee, Djd Of The Knee, Hypertrophic Arthritis Of The Knee, Oa Of The Knee, Osteoarthrosis Of The Knee.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Gelsyn-3 16.8 Mg/2 Ml Syringe | Maintenance | Inject 2 milliliters (16.8 mg) into the affected knee(s) by intra-articular route every 7 days for 3 weeks. |
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Infection of bone, joint, skin, or soft tissue of knee
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Anaphylaxis
- Drug fever
- Skin rash
- Urticaria
More Frequent
- Abdominal pain with cramps
- Anorexia
- Diarrhea
- Ecchymosis
- Gastrointestinal irritation
- Headache disorder
- Injection site sequelae
- Knee inflammation
- Nausea
- Pruritus of skin
- Vomiting
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Osteoarthritis of the knee | ||
| M17 | ICD10CM | Osteoarthritis of knee |
| M17.0 | ICD10CM | Bilateral primary osteoarthritis of knee |
| M17.1 | ICD10CM | Unilateral primary osteoarthritis of knee |
| M17.10 | ICD10CM | Unilateral primary osteoarthritis, unspecified knee |
| M17.11 | ICD10CM | Unilateral primary osteoarthritis, right knee |
| M17.12 | ICD10CM | Unilateral primary osteoarthritis, left knee |
| M17.2 | ICD10CM | Bilateral post-traumatic osteoarthritis of knee |
| M17.3 | ICD10CM | Unilateral post-traumatic osteoarthritis of knee |
| M17.30 | ICD10CM | Unilateral post-traumatic osteoarthritis, unspecified knee |
| M17.31 | ICD10CM | Unilateral post-traumatic osteoarthritis, right knee |
| M17.32 | ICD10CM | Unilateral post-traumatic osteoarthritis, left knee |
| M17.4 | ICD10CM | Other bilateral secondary osteoarthritis of knee |
| M17.5 | ICD10CM | Other unilateral secondary osteoarthritis of knee |
| M17.9 | ICD10CM | Osteoarthritis of knee, unspecified |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.